Stock Report

Narayana Hrudayalaya Reports Q1 FY27 Results: Consolidated Revenue Surges 78% YoY to ₹26,836 Million



Posted On : 2026-08-01 14:28:46( TIMEZONE : IST )

Narayana Hrudayalaya Reports Q1 FY27 Results: Consolidated Revenue Surges 78% YoY to ₹26,836 Million

Narayana Hrudayalaya Limited, a leading healthcare service provider in India and internationally, announced its financial and operational performance for the first quarter ended June 30, 2026 (Q1 FY27).

Driven by sustained growth across domestic hospitals, expansion in Cayman operations, and the integration of its UK business, the healthcare group reported consolidated operating revenue of ₹26,836 million, marking a 78.0% year-on-year (YoY) increase compared to ₹15,073 million in Q1 FY26. Sequentially, consolidated revenue grew 3.5% quarter-on-quarter (QoQ).

Group Financial Performance Overview

1. Revenue Breakdown by Region

India Operations: Revenue grew 17.0% YoY (and +5.9% QoQ) to ₹13,247 million, compared to ₹11,326 million in Q1 FY26.

Cayman Operations: Revenue rose 38.9% YoY to ₹5,514 million (US$ converted at ₹94.71 for YTD FY27 vs. ₹88.31 for FY26), down 1.8% QoQ.

UK Operations: Contributed ₹8,257 million in revenue for Q1 FY27, growing 2.1% QoQ (converted at GBP to USD rate of 1.34).

2. Profitability & Margins

Consolidated EBITDA: Rose 40.0% YoY to ₹5,052 million (vs. ₹3,607 million in Q1 FY26), though declining 6.4% QoQ.

EBITDA Margin: Stood at 18.8%, compared to 23.9% in Q1 FY26, reflecting the operational cost dynamics and regional mix adjustments post-UK integration.

Profit After Tax (PAT): Increased 5.7% YoY to ₹2,073 million (vs. ₹1,961 million in Q1 FY26), down 9.2% QoQ.

PAT Margin: Reported at 7.7%, compared to 13.0% in Q1 FY26.

Balance Sheet & Leverage Position

As of June 30, 2026, Narayana Hrudayalaya's net debt (Total Borrowings less Cash, Bank Balances, and Investments) stood at ₹19,671 million, translating to a comfortable net debt-to-equity ratio of 0.42.

The company's debt profile includes foreign currency obligations consisting of US$ 115 million and GBP £150 million.

Clinical Milestones & Surgical Technology Deployments

During the quarter, the company expanded its clinical capabilities and advanced robotic surgical programs across flagship units:

Narayana Institute of Cardiac Sciences, Bengaluru Completed 2,137 cardiac surgeries in Q1 FY27.

Performed 19 Pulsed Field Ablation (PFA) procedures for Atrial Fibrillation in June 2026 following its launch in India.

Narayana Hospital, Gurugram Operationalized the CUVIS Ortho Robotic System for joint procedures.

Deployed a Thulium Laser System enabling advanced, minimally invasive urological surgeries.

Advanced Surgical & Robotic Procedures

Across its network, the group successfully executed complex robotic procedures during Q1 FY27, including:

Robotic Common Bile Duct (CBD) Exploration.

Robot-assisted Hiatus and Ventral Hernia Repair combined with Paraumbilical Lump Excision.

Robotic Simple Prostatectomy.

Robotic Cytoreductive Surgery.

Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said "The first quarter of FY27 has started on a strong note, with all our geographies delivering a robust performance. Despite Q1 being a seasonally weaker quarter, India delivered robust growth, driven by higher patient footfall, a continued focus on high-end and complex procedures, and strong underlying customer demand. Our expanding Integrated Care ecosystem - clinics and insurance - continues to reinforce this momentum, enhancing patient outreach and strengthening the funnel into our hospitals network.

Our Cayman business continues to perform well, with the hospitals business ably supported by the One Health insurance platform, which has further strengthened patient access and affordability. Our newly acquired UK business, now in its third quarter under NH, has remained stable, with integration efforts progressing well and the separation from its erstwhile parent approaching completion. We are pleased with the performance of this business so far and remain confident of its growth potential going forward. We thank the investor community for their continued faith in us, and remain confident of delivering on our expectations for the year."

Shares of Narayana Hrudayalaya Ltd. was last trading in BSE at Rs. 2027.55 as compared to the previous close of Rs. 2079.35. The total number of shares traded during the day was 10153 in over 965 trades.

The stock hit an intraday high of Rs. 2089.50 and intraday low of 2012.30. The net turnover during the day was Rs. 20829556.00.

Source : Equity Bulls

Keywords

NarayanaHrudayalaya INE410P01011 HealthcareFacilities Q1FY27 Q1FY2027 ResultUpdate